ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - tretinoin - קפסולות - tretinoin 10 mg - tretinoin

ישראל - עברית - Ministry of Health

kivema ltd - cromoglicic acid as sodium - טיפות עיניים - cromoglicic acid as sodium 20 mg/ml - cromoglicic acid

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - ganciclovir as sodium - אבקה להכנת תמיסה לאינפוזיה - ganciclovir as sodium 500 mg - ganciclovir

ישראל - עברית - Ministry of Health

kivema ltd - azelastine hydrochloride - טיפות עיניים - azelastine hydrochloride 0.05 %w/v - azelastine

ישראל - עברית - Ministry of Health

bayer israel ltd - hypericum perforatum - טבליות מצופות פילם - hypericum perforatum 612 mg - symptoms of mild to moderate depression. treatment is recommended for up to 12 weeks.

ישראל - עברית - Ministry of Health

taro international ltd, israel - clindamycin phosphate - ג'ל - clindamycin phosphate 1 %w/w - clindamycin - clindamycin - zindaclin is indicated for the treatment of acne vulgaris.

ישראל - עברית - Ministry of Health

mediline ltd. - ferrous as iron iii hydroxide sucrose complex 100 mg / 5 ml - concentrate for solution for infusion - iron-sorbitol-citric acid complex - severe iron deficiency only when oral administration has been found impossible. in cases of gastro-intestinal malobsorption which rules out oral therapy, patients on dialysis treated with erythropoietin. the diagnosis of iron deficiency must be based on appropriate laboratory tests.

ישראל - עברית - Ministry of Health

mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

ישראל - עברית - Ministry of Health

mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

ישראל - עברית - Ministry of Health

mediline ltd. - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.